Overexpression of tyrosine kinase receptors has been noted in thyroid cancer cells, including those for fibroblast growth factor, epidermal growth factor (EGF), hepatocyte growth factor (c-Met), vascular endothelial growth factor (VEGF), insulin, and insulin growth factor 1. The gene discussed is EGF; the disease is thyroid gland carcinoma.